Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
On the otc markets page it’s gone to full delinquent “grey market”.
You may be right, but last I recall seeing it was just a stop sign.
Anyone else know?
Well, full stop today. Shame.
Had some hope for this to be successful.
Could be an exciting week. What’s that old adage? Filings/earnings on a Friday/post market not the best sign, but filings/earnings on a Monday, a very positive sign!
“8k will quickly follow” could that be tomorrow too?
The benefits of one filing, haha. Hopefully now they’ll kick things in gear and get on with it.
Have an enjoyable thanksgiving week yourself, Cuenca, and all!
Agreed. But if that is truly why they were silent then I’ll give them the benefit of the doubt. I would love to see the tech they are working with (assuming it’s what people here have claimed it to be).
I really want this to succeed as you all do as well. I’ve got plenty of time to wait and not too much to lose. Potentially a lot to gain.
GLTA.
Those last few lines give me hope. I just now had a chance to go on EDGAR to look at the 8k and, I too, initially missed the PR embedded underneath it.
“Much of the silence from the Management and BOD over the last year stemmed from the focus of the agenda on securing proprietary processes and patents relating to Magnatech and other technologies and patents that Mr. Snaper wished to make certain would continue after his passing. The Company is well prepared to commercialize some of his amazing body of work and will endeavor to carry on his Legacy.”
I do as well and agree with your statement.
Just felt the need to note I’m not bashing yours or anyone else’s stance on the matter. Was meant to be open ended to whomever reads it.
No malice intended. Best of luck to you brother.
“Update on 10Q & 8KA. We are hoping to file the late tomorrow. The delay albeit unfortunate is expected to result in an uptick of multi-millions of dollars to the balance sheet and we felt worth the delay & was necessary based on the auditor’s last review. See Letter Image $VYST”
Yes, key word is “hoping”. Should be this week at worst. The delay sucks. I agree and can’t dispute it, but remaining optimistic point forward. That’s my personal stance only; you’re all entitled to your own and I will respect that.
Best of luck to everyone.
They hope to file late tomorrow.
Just now had a chance to watch the video. Definitely excited for what’s to come in 2020. Hopefully we get good price movement soon.
I’m going to try and get up to 100k shares under $10k and let that ride.
Absolutely!
MOU for the land has been executed!
https://blackiron.com/black-iron-and-ukrainian-government-agree-on-terms-for-essential-land-transfer/
20% now
Just listened to the video. Sounds like they’re definitely going to try and push it through this time.
I’m extremely excited and will probably increase my position soon. GL to you as well!
Just stepped out of a meeting and saw the tweet haven’t read it yet tho.
Definitely do consider reading the entire shareholder letter.
http://www.viewproxy.com/Protalix/2019SM/ShareholderLetter2019.pdf
Let me know if that link doesn’t work
As part of our efforts to preserve our ongoing clinical development and to realize future benefits of commercial success, our Board of Directors, along with our Management team, have determined that it is in the company’s best interest to make certain changes to our capital structure. Accordingly, we have filed a proxy statement asking our stockholders to approve an amendment to our Certificate of Incorporation proposing the following two changes:
1) A reverse stock split at a ratio of not less than 1-for-10 and not greater than 1-for-20, with the exact ratio to be set within that range at the discretion of our Board of Directors before the day prior to the special meeting of stockholders without further approval or authorization of our stockholders.
2) A reduction in the total number of shares of our common stock that we are authorized to issue from 350 million to 120 million shares.
I’d encourage everyone to read the proxy statement for what it’s worth. Got an email through fidelity about it this morning.
May be old news to some.
I’d agree with that assessment, but for some reason the market doesn’t.
They just posted interim data last week from their bridge trial.
Kronberg posted a link 10/17. Do you mean any more data since that came out?
50% movement today?
Awesome. Thanks Chris! Hope you’re doing well.
Just to be clear on how I understood his comments to avoid misleading anyone, feel free to correct my understanding:
Naval is working for the fund manager who deals with the Opportunity Zone funding, yes, BUT Snapper’s office is just outside of the OZ. Bordered on 3 sides by the boundary.
CTDT can’t get the full funding from the OZ Fund, but they CAN potentially get (I think I recall) up to 10% of the full $50 million.
C.C. Coming in hot off the top rope out the woodwork.
Protalix: A Close Look At BRIDGE's "Positive"12-Month Interim Data $PLX https://seekingalpha.com/article/4297632
For more information please contact Chas Radovich at 714-323-1110 or via email at admin@centaurustechnologiesinc.com
His phone number has been posted many times and I believe it is listed on their PR’s.
Sorry, I don’t have it in front of me, but should be easy to find!
Cheers.
Still made money. Just putting the point out there.
I realize it’s well different in many regards but the process is similar to what VYST outlined.
Best of luck to you.
I think I recall seeing your post, but I slept since then.
Let me set the record straight as I don’t want my sentiment to go misunderstood or misinterpreted.
I’ve been in this for about 3(?) years now. Maybe 2.5. Well before the Chiesi deal was announced. Back when it went from 80 cents to $1.33 then cratered. I got in this because after researching the company, I had trouble finding the fallacy the market seems to have found. It seemed to me like the data was solid in comparison to the other products and that their approach with plant cells was novel. That their technology and platform could prove well for them. A lot has happened since then and the fundamentals seem to still be there short of the convertible notes and delays in trial registration.
I’m still long this and think it will prove a winning investment in the years to come. I just have more doubts now... well see more uncertainty now. I’ve even averaged down three times to below .30. I haven’t had much fortune with companies undergoing a RS but it’s NOT always a negative.
From what I’ve seen on this board recently, i have trouble deducing the rationale for reducing the shares available but I imagine there is a grander plan the public isn’t privy to.
Cheers and GL to you all.
I was in another stock, Portage Biotech (PTGEF) who is essentially a holding company comprised of multiple biotech companies in the very early stages. Ptgef was trading at $0.26/share. Their model was to invest in those companies and they then spun off one of their assets as a whole new entity, Biohaven Pharmaceuticals, as a separate publically traded company. They relinquished their ownership to shareholders in the form of a special dividend approximately two years ago. Upon run-up closer to “IPO” PTGEF rose to $0.60/share to reflect the value of the BHVN investment while BHVN “IPO’d” around $17/share. Bhvn then quickly moved to ~$35/share. Today BHVN is trading at $44/share for a company with $0 revenue (but late stage trial data for what its worth). The conversion rate of the dividend was about 1 BHVN share per 22 shares of PTGEF owned.
GRANTED this isn’t the EXACT same case as VYST and RxAir as they have different business models, are in different industries, and biotechs trade on trial data and future potential, BUT there are some similarities of how it works. I just wanted to share that story with you all.
I do not know what will come of this dividend but I see it as a current positive to shareholders. I do not know what the “IPO” price of RxAir inc. will be nor do I know what the conversion rate will be.
Just wanted to present the case for anyone who may not believe this is possible, think this is a sham, or what have you.
Forewarning: the event was taxable and the basis was treated as $0.00/share so it was a full capital gain according to another fella on that board with whom I exchanged correspondence.
I’m going to hold VYST and see what comes of it. That’s my opinion and mine alone. GLTA!
Just when all hope seemed lost they pull this. Happy and all but is it worth staying long (-ish)...
Went through a similar event as this spinoff with another company I hold. Was very beneficial to shareholders long term. Excited to see what comes of it!
Queue the three to five more posts about new tweet and link, lol
New tweet:
Update from Vystar, enclosed in the attached image. $VYST pic.twitter.com/TJ5L9JWkgd
— Vystar Corporation (@VystarCompany) October 2, 2019
That price analysis is great. Currently right at the mid-range of what we discussed before.
One thing that may hold the valuation back long term is if, and how much of their financing, is share issuances and convertible notes.
Boy would I be thrilled to see closer to their true value assessment of $31/share!
That same article you posted hit US Newswires today. Saw it on yahoo finance just now. The article today had one KEY point in it that the one you posted left out.
Here it is:
“Last week, Black Iron's CEO also met with the owner of a Middle East steel mill that expressed a serious interest to make a substantial equity investment into the construction of Black Iron's project in exchange for offtake potentially alongside Glencore. This company is planning to construct a direct reduction pellet plant that would benefit from the very short, low cost shipping distance from Ukraine. There are very few global suppliers of direct reduction iron ore given the need to produce a product containing 70% iron with ultra low contaminants which Black Iron expects to produce from its project. Globally respected commodities analysis firm CRU forecasts there will be a 40 million tonne per year shortfall in supply versus needed demand of direction reduction pellet feed over the next fifteen years.”
I noticed it! I’m particularly encouraged by the points of site visits COMPLETED and signing MOU’s now and BINDING CONTRACTS by year end.
Excited to hear what more they have in the works:
“a more detailed announcement outlining the Company’s plan to fund project construction with potentially only a small amount of equity from the public markets will soon be provided to investors.”
Glad they finally completed enrollment in all three studies. Hopefully now they can start making material progress....
“The SEC's OCA responded to our inquiry and has agreed with Vystar's professional team that the merger with Rotmans should be treated as a traditional merger, not a reverse merger. Having this issue resolved allows us to move forward with completing & presenting financials! $VYST”